Status:
UNKNOWN
The Effect of Working at Home to Reduce Risk of Respiratory Infection
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
The National Institute of Occupational Health, Norway
Conditions:
Respiratory Tract Infections
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The researchers will recruit volunteers from various organisations who are willing and able to be randomised to either working from home for 4 weeks followed by working in the office for 4 weeks, or v...
Detailed Description
Working in the office entails to various extent contact with colleagues, and for some it includes close contact to others when using public transport to and from work. This likely increases the risk o...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Over 18 years old
- Employee in a company/organisation that has agreed to let their employees take part
- Willing and able to work form home for 4 weeks (most of the time)
- Exclusion crieria:
- \- Unable to work from home
Exclusion
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05298488
Start Date
March 14 2022
End Date
September 30 2023
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norwegian Institute of Public Health
Oslo, Norway, 0213